UCLB logo

UCLB

Europe, England, United Kingdom, London

Description

UCLB is the commercialisation company of UCL that brings to market truly world-leading, world-changing technologies and innovations.

Investor Profile

UCLB has made 39 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (69%)
  • Series A (8%)
  • Series Unknown (8%)
  • Series B (5%)
  • Series C (3%)
  • Pre Seed (3%)
  • Grant (3%)
  • Angel (3%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Software
  • Therapeutics
  • Pharmaceutical
  • Medical Device
  • Machine Learning
  • Artificial Intelligence (Ai)
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UCLB frequently co-invest with?

The Francis Crick Institute
Europe, England, United Kingdom, London
Co-Investments: 1
AlbionVC
Europe, England, United Kingdom, London
Co-Investments: 4
UCL Technology Fund
Europe, England, United Kingdom, London
Co-Investments: 3
Sixth Element Capital
Europe, Buckinghamshire, United Kingdom, Berkhamsted
Co-Investments: 1
Imperial Innovations
Europe, England, United Kingdom, London
Co-Investments: 3
London Co-Investment Fund
Europe, England, United Kingdom, London
Co-Investments: 2
Cancer Research Horizons
Europe, England, United Kingdom, London
Co-Investments: 1
AI Seed
Europe, England, United Kingdom, London
Co-Investments: 2
Syncona Partners LLP
Europe, England, United Kingdom, London
Co-Investments: 2
Wellcome Trust
Europe, England, United Kingdom, London
Co-Investments: 2

What are some of recent deals done by UCLB?

Carbon Re

London, England, United Kingdom

Carbon Re is a climate technology company developing artificial intelligence to decarbonize energy-intensive industries.

Artificial Intelligence (AI)Machine LearningManufacturingSoftware
Pre SeedOct 20, 2021
Amount Raised: $1,402,934
Astroscreen

London, England, United Kingdom

Astroscreen protects brands and defends democracy from harmful social media manipulation campaigns also known as astroturfing.

Information Technology
SeedApr 18, 2019
Amount Raised: $1,000,000
Hazy

London, England, United Kingdom

Hazy is the world’s leading synthetic data company, re-engineering enterprise data so that it’s faster, easier and safer to use.

Enterprise SoftwareMachine LearningSoftware
SeedMay 2, 2018
Amount Raised: $1,800,000
Intrinsic Semiconductor Technologies

London, England, United Kingdom

Intrinsic Semiconductor Technologies is established to developed silicon-oxide based RRAM technologies.

Artificial Intelligence (AI)ElectronicsInformation TechnologyManufacturingSemiconductor
SeedJan 1, 2018
Correvate

London, England, United Kingdom

Correvate was formed to commercialise point cloud processing technology (Vercator) that emerged from UCL.

3D TechnologyBig DataCivil EngineeringCloud ComputingCloud Data ServicesComputerComputer VisionConstructionGeospatial
SeedJan 1, 2018
Autolus

London, England, United Kingdom

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

BiopharmaBiotechnologyMedicalPharmaceutical
Series CSep 26, 2017
Amount Raised: $80,000,000
Appredict

London, England, United Kingdom

Appredict is a data analysis company that specialises in analysing and understanding the development lifecycle of apps.

AnalyticsData StorageSoftware
SeedJan 1, 2017
Intract Pharma

London, England, United Kingdom

Intract Pharma is an oral drug delivery licensing and product development company offering a range of proprietary formulation technologies.

BiotechnologyLife SciencePharmaceutical
SeedJan 1, 2017
Apollo Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
SeedJan 1, 2017
Achilles Therapeutics

London, England, United Kingdom

Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

BiotechnologyHealth CareTherapeuticsWellness
SeedSep 28, 2016
Amount Raised: $17,215,632